Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
NGVT
|
Stuart Edward Woodcock Jr.
EVP, President Perf Materials |
BUY
Grant, award, or other acquisition
|
Direct | 2,073 Added 7.31% |
-
|
Feb 28
2022 |
NGVT
|
Michael P. Smith
EVP, President Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct | 469 Reduced 2.11% |
$32,000
$68.23 p/Share
|
Feb 28
2022 |
NGVT
|
Richard Allen White Jr
SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct | 106 Reduced 3.46% |
$7,232
$68.23 p/Share
|
Feb 28
2022 |
NGVT
|
Richard Allen White Jr
SVP and Pres, Perf Chemicals |
BUY
Grant, award, or other acquisition
|
Direct | 1,393 Added 24.23% |
-
|
Feb 28
2022 |
NGVT
|
Phillip John Platt
SVP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 140 Reduced 2.3% |
$9,552
$68.23 p/Share
|
Feb 28
2022 |
NGVT
|
Phillip John Platt
SVP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct | 733 Added 9.89% |
-
|
Feb 28
2022 |
FHB
|
Neill Char
VICE CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Direct | 806 Reduced 4.8% |
$23,430
$29.07 p/Share
|
Feb 28
2022 |
FHB
|
Christopher L Dods
VICE CH & CHIEF OPERATING OFCR |
SELL
Payment of exercise price or tax liability
|
Direct | 1,690 Reduced 3.52% |
$49,128
$29.07 p/Share
|
Feb 28
2022 |
FHB
|
Ralph Mesick
VICE CH & CHIEF RISK OFCR |
SELL
Payment of exercise price or tax liability
|
Direct | 1,943 Reduced 3.62% |
$56,483
$29.07 p/Share
|
Feb 28
2022 |
FHB
|
Lance A. Mizumoto
VICE CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Direct | 2,916 Reduced 8.4% |
$84,768
$29.07 p/Share
|
Feb 28
2022 |
FHB
|
Alan Arizumi
VICE CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Direct | 2,187 Reduced 4.38% |
$63,576
$29.07 p/Share
|
Feb 28
2022 |
FHB
|
Alan Arizumi
VICE CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Indirect | 384 Reduced 7.14% |
$11,163
$29.07 p/Share
|
Feb 28
2022 |
MMSI
|
Fred P Lampropoulos
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,832 Reduced 0.79% |
$509,315
$65.03 p/Share
|
Feb 28
2022 |
MMSI
|
Raul Parra Jr.
CFO AND TREASURER |
SELL
Payment of exercise price or tax liability
|
Direct | 1,942 Reduced 21.64% |
$126,288
$65.03 p/Share
|
Feb 28
2022 |
MMSI
|
Ronald Frost
CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 1,942 Reduced 11.37% |
$126,288
$65.03 p/Share
|
Feb 28
2022 |
MMSI
|
Brian G. Lloyd
CHIEF LEGAL OFFICER, SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct | 1,942 Reduced 16.92% |
$126,288
$65.03 p/Share
|
Feb 28
2022 |
MMSI
|
Joseph Wright
CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 1,942 Reduced 10.24% |
$126,288
$65.03 p/Share
|
Feb 28
2022 |
ISRG
|
Gary S Guthart
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,918 Reduced 19.3% |
$556,853
$290.33 p/Share
|
Feb 28
2022 |
ISRG
|
Gary S Guthart
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,867 Added 28.01% |
-
|
Feb 28
2022 |
ISRG
|
David J. Rosa
President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,119 Reduced 0.95% |
$324,879
$290.33 p/Share
|
Feb 28
2022 |
ISRG
|
David J. Rosa
President |
BUY
Exercise of conversion of derivative security
|
Direct | 2,256 Added 1.88% |
-
|
Feb 28
2022 |
ISRG
|
Myriam Curet
EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,119 Reduced 32.16% |
$324,879
$290.33 p/Share
|
Feb 28
2022 |
ISRG
|
Myriam Curet
EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,256 Added 39.33% |
-
|
Feb 28
2022 |
ISRG
|
Robert De Santis
EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct | 1,008 Reduced 13.69% |
$292,653
$290.33 p/Share
|
Feb 28
2022 |
ISRG
|
Robert De Santis
EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct | 2,175 Added 22.8% |
-
|
Feb 28
2022 |
ISRG
|
Reiter Kara Andersen
Sr VP General Counsel & CCO |
SELL
Payment of exercise price or tax liability
|
Direct | 560 Reduced 3.01% |
$162,585
$290.33 p/Share
|
Feb 28
2022 |
ISRG
|
Reiter Kara Andersen
Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,128 Added 5.71% |
-
|
Feb 28
2022 |
ISRG
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct | 539 Reduced 13.63% |
$156,488
$290.33 p/Share
|
Feb 28
2022 |
ISRG
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct | 1,257 Added 24.12% |
-
|
Feb 28
2022 |
ISRG
|
Fredrik Widman
VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 295 Reduced 9.9% |
$85,647
$290.33 p/Share
|
Feb 28
2022 |
ISRG
|
Fredrik Widman
VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 852 Added 22.23% |
-
|
Feb 28
2022 |
ISRG
|
Henry L Charlton
EVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct | 654 Reduced 3.67% |
$189,876
$290.33 p/Share
|
Feb 28
2022 |
ISRG
|
Henry L Charlton
EVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct | 1,449 Added 7.52% |
-
|
Feb 28
2022 |
ISRG
|
Marshall Mohr
Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct | 1,119 Reduced 19.8% |
$324,879
$290.33 p/Share
|
Feb 28
2022 |
ISRG
|
Marshall Mohr
Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct | 2,256 Added 28.53% |
-
|
Feb 28
2022 |
EQH
|
Seth P Bernstein
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,300 Reduced 3.2% |
$75,118
$32.66 p/Share
|
Feb 28
2022 |
EQH
|
Nick Lane
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,246 Reduced 4.01% |
$171,334
$32.66 p/Share
|
Feb 28
2022 |
EQH
|
William James Iv Eckert
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 999 Reduced 3.27% |
$32,627
$32.66 p/Share
|
Feb 28
2022 |
EQH
|
Robin M Raju
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,125 Reduced 1.79% |
$36,742
$32.66 p/Share
|
Feb 28
2022 |
EQH
|
Jeffrey J Hurd
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,997 Reduced 4.01% |
$163,202
$32.66 p/Share
|
Feb 28
2022 |
EQH
|
Mark Pearson
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 21,648 Reduced 4.07% |
$707,024
$32.66 p/Share
|
Feb 28
2022 |
CVS
|
Prem S Shah
EVP and Group President |
SELL
Payment of exercise price or tax liability
|
Direct | 141 Reduced 0.23% |
$14,615
$103.65 p/Share
|
Feb 28
2022 |
PFE
|
Jennifer B. Damico
SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 740 Reduced 3.75% |
$34,736
$46.94 p/Share
|
Feb 28
2022 |
PFE
|
Michael Mc Dermott
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,384 Reduced 1.84% |
$64,965
$46.94 p/Share
|
Feb 28
2022 |
PFE
|
William R Carapezzi Jr
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,795 Reduced 2.46% |
$84,257
$46.94 p/Share
|
Feb 28
2022 |
ANAT
|
Russell S. Moody |
SELL
Open market or private sale
|
Indirect | 21,967 Reduced 28.13% |
$4,155,058
$189.15 p/Share
|
Feb 28
2022 |
ANAT
|
Frances A Moody Dahlberg
Director |
SELL
Open market or private sale
|
Indirect | 21,024 Reduced 26.92% |
$3,976,479
$189.14 p/Share
|
Feb 28
2022 |
HBP
|
Jon P Vrabely
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 5,870 Reduced 0.59% |
$54,532
$9.29 p/Share
|
Feb 28
2022 |
ENOV
|
Patricia A Lang
SVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct | 10,153 Reduced 22.53% |
$419,014
$41.27 p/Share
|
Feb 28
2022 |
ENOV
|
Christopher M Hix
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 31,207 Reduced 17.69% |
$1,279,487
$41.0 p/Share
|
Feb 28
2022 |